Methods | Design: Randomised cross‐over trial (2 periods) Setting: USA |
|
Participants | N=35, healthy males and females, aged 18‐35 years Participants remained awake throughout overnight sessions between 17.00 and 05.00 Experimental sessions were at least one week apart |
|
Interventions |
Drugs were identical in appearance Caffeine/placebo capsules were consumed at 03.30 |
|
Outcomes | Simple reaction‐time task, two‐choice reaction‐time task performed at 03.00, 04.00 and 05.00 | |
Notes | Funded by a grant from Atlas Labs, USA and by National Institute on Drug Abuse, USA. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Adequate sequence generation? | Low risk | Correspondence with author ‐ computer generated randomisation. |
Allocation concealment? | Low risk | Central allocation. |
Blinding? All outcomes | Low risk | Double‐blind. |
Incomplete outcome data addressed? All outcomes | Unclear risk | Insufficient reporting of attrition/exclusions to permit judgement of 'Yes' or 'No'. |
Free of selective reporting? | Unclear risk | All outcomes described in Methods section are reported in the Results. |
Free of other bias? | Low risk | The study appears to be free of other sources of bias. |